View printer-friendly version |
<< Back |
First Quarter Fiscal 2025 Highlights
-
Quarterly net sales of
$785.9 million -
Quarterly net income of
$150.0 million , or$3.06 per diluted share - Quarterly record for total dozens sold and specialty dozens sold
-
Cash dividend of approximately
$50.0 million , or$1.02 per share, pursuant to the Company’s established dividend policy
Overview
“We believe that today’s consumers are looking for affordable and nutritious protein options and that our shell eggs and egg products meet that need. In addition, our ability to offer a diverse product mix has been a distinct competitive advantage for
“Subsequent to the end of the first quarter of fiscal 2025, Hurricane Helene made landfall in the southeastern
Sales Performance & Operating Highlights
“For the first fiscal quarter, we sold 310.0 million dozens shell eggs compared with 273.1 million dozens for the first quarter of fiscal 2024. Sales of conventional eggs totaled 200.0 million dozens, compared with 181.5 million dozens for the prior-year period, an increase of 10.2%. Specialty egg volumes were 20.1% higher with 110.0 million dozens sold for the first quarter of fiscal 2025 compared with 91.6 million dozens sold for the first quarter of fiscal 2024.
“Net income attributable to
“Overall, our first quarter farm production costs per dozen were 11.7% lower compared to the prior-year period, primarily due to more favorable commodity pricing for key feed ingredients. For the first quarter of fiscal 2025, feed costs per dozen were down 17.3% compared with the first quarter of fiscal 2024. Our egg purchases and other (including change in inventory) costs increased significantly quarter-over-quarter, primarily due to higher shell egg prices as well as an increase in dozens purchased due to the loss of production caused by the HPAI outbreaks at our facilities, described below.
“Current indications for corn supply project an overall better stocks-to-use ratio, implying more favorable prices in the near term. However, as we continue to face uncertain external forces including weather patterns and global supply chain disruptions, price volatility could remain,” said Bowman.
|
13 Weeks Ended |
||||||
|
|
|
|
||||
Dozen Eggs Sold (000) |
|
309,979 |
|
|
|
273,126 |
|
Conventional Dozen Eggs Sold (000) |
|
199,989 |
|
|
|
181,530 |
|
Specialty Dozen Eggs Sold (000) |
|
109,990 |
|
|
|
91,596 |
|
Dozen Eggs Produced (000) |
|
266,839 |
|
|
|
250,365 |
|
% Specialty Sales (dozen) |
|
35.5 |
% |
|
|
33.5 |
% |
% Specialty Sales (dollars) |
|
34.2 |
% |
|
|
47.7 |
% |
Net Average Selling Price (per dozen) |
$ |
2.392 |
|
|
$ |
1.589 |
|
Net Average Selling Price Conventional Eggs (per dozen) |
$ |
2.424 |
|
|
$ |
1.241 |
|
Net Average Selling Price Specialty Eggs (per dozen) |
$ |
2.335 |
|
|
$ |
2.278 |
|
Feed Cost (per dozen) |
$ |
0.494 |
|
|
$ |
0.597 |
|
HPAI & Table Egg Supply Outlook
Outbreaks of HPAI have continued to occur in
During the third and fourth quarters of fiscal 2024,
The Company remains dedicated to robust biosecurity programs across its locations; however, no farm is immune from HPAI. HPAI is currently widespread in the wild bird population worldwide. The extent of possible future outbreaks, with heightened risk during the migration seasons, and more recent HPAI events, which have been directly linked to dairy cattle operations, cannot be predicted. According to the
Looking Ahead
Miller added, “We are proud of our ability to consistently execute our growth strategy in a dynamic environment with favorable results. We commend our dedicated managers and employees whose shared commitment to operational excellence and responsible and sustainable production have distinguished
Dividend Payment
For the fourth quarter of fiscal 2024,
About
Forward Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s
|
||||||||
FINANCIAL HIGHLIGHTS |
||||||||
(Unaudited) |
||||||||
(In thousands, except per share amounts) |
||||||||
|
||||||||
SUMMARY STATEMENTS OF INCOME |
||||||||
|
|
13 Weeks Ended |
||||||
|
|
|
|
|
||||
Net sales |
|
$ |
785,871 |
|
|
$ |
459,344 |
|
Cost of sales |
|
|
538,653 |
|
|
|
413,911 |
|
Gross profit |
|
|
247,218 |
|
|
|
45,433 |
|
Selling, general and administrative |
|
|
61,932 |
|
|
|
52,246 |
|
Loss on involuntary conversions |
|
|
146 |
|
|
|
- |
|
Gain on disposal of fixed assets |
|
|
(1,817 |
) |
|
|
(56 |
) |
Operating income (loss) |
|
|
186,957 |
|
|
|
(6,757 |
) |
Other income, net |
|
|
10,996 |
|
|
|
7,490 |
|
Income before income taxes |
|
|
197,953 |
|
|
|
733 |
|
Income tax expense |
|
|
48,363 |
|
|
|
322 |
|
Net income |
|
|
149,590 |
|
|
|
411 |
|
Less: Loss attributable to noncontrolling interest |
|
|
(386 |
) |
|
|
(515 |
) |
Net income attributable to |
|
$ |
149,976 |
|
|
$ |
926 |
|
|
|
|
|
|
|
|
||
Net income per common share: |
|
|
|
|
|
|
||
Basic |
|
$ |
3.08 |
|
|
$ |
0.02 |
|
Diluted |
|
$ |
3.06 |
|
|
$ |
0.02 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
||
Basic |
|
|
48,761 |
|
|
|
48,690 |
|
Diluted |
|
|
48,932 |
|
|
|
48,840 |
|
|
|
|
|
|
|
|
|
||||||
FINANCIAL HIGHLIGHTS |
||||||
(Unaudited) |
||||||
(In thousands) |
||||||
|
||||||
SUMMARY BALANCE SHEETS |
||||||
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
753,590 |
|
$ |
812,377 |
Receivables, net |
|
|
282,551 |
|
|
162,442 |
Inventories, net |
|
|
293,182 |
|
|
261,782 |
Prepaid expenses and other current assets |
|
|
14,156 |
|
|
5,238 |
Current assets |
|
|
1,343,479 |
|
|
1,241,839 |
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
960,070 |
|
|
857,234 |
Other noncurrent assets |
|
|
86,459 |
|
|
85,688 |
Total assets |
|
$ |
2,390,008 |
|
$ |
2,184,761 |
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
$ |
275,444 |
|
$ |
189,983 |
Dividends payable |
|
|
49,971 |
|
|
37,760 |
Current liabilities |
|
|
325,415 |
|
|
227,743 |
|
|
|
|
|
|
|
Deferred income taxes and other liabilities |
|
|
165,530 |
|
|
159,975 |
Stockholders' equity |
|
|
1,899,063 |
|
|
1,797,043 |
Total liabilities and stockholders' equity |
|
$ |
2,390,008 |
|
$ |
2,184,761 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241001974301/en/
(601) 948-6813
Source: